Sherlock Biosciences

Sherlock Biosciences is a biotechnology company revolutionizing molecular diagnostics by leveraging the power of CRISPR and synthetic biology. They are committed to democratizing and decentralizing testing, providing accurate, actionable information wherever and whenever it is needed. Their goal is to make rapid, accurate, and affordable diagnostic tests accessible to everyone, even in low-resource settings. Sherlock has developed two proprietary platforms: SHERLOCK, a CRISPR-based system for DNA and RNA detection, and INSPECTR, which uses synthetic biology to create programmable molecular diagnostic devices. These platforms allow for the creation of point-of-need tests that can be used in a variety of settings, from home testing to global health outbreak response.

Sherlock Biosciences is focused on disrupting the current healthcare paradigm by empowering individuals to control their health decisions through easy access to diagnostic information. The company has garnered significant recognition for its work, including the first FDA-authorized use of CRISPR technology and the PM360 Trailblazer 2022 Company of the Year award for Medical Device/Diagnostics. Their dedication to innovation, coupled with their commitment to improving global health equity, makes Sherlock Biosciences a key player in the future of molecular diagnostics.

Sherlock Biosciences offers unlimited vacation, parental leave, and voting leave, demonstrating a commitment to employee well-being and flexibility. While specific work-from-home policies are not explicitly mentioned, the generous leave offerings suggest a supportive environment for employees to manage their work-life balance.

Sherlock Biosciences offers a robust benefits package to its employees, including comprehensive medical, dental, and vision insurance, life insurance, flexible spending accounts (FSA), disability coverage, unlimited vacation, parental leave, a 401(k) plan, and equity. Beyond the standard benefits, the company provides commuter benefits, lunch delivery programs, voting leave, and an employee referral program. This demonstrates Sherlock's commitment to creating a comprehensive and supportive work environment for its employees.

Sherlock Biosciences is dedicated to democratizing and decentralizing diagnostic testing, making rapid, accurate, and affordable molecular diagnostics accessible to people at the point-of-need. This mission drives them to engineer biology, using CRISPR and synthetic biology, to create simple-to-use devices that empower individuals to control their health decisions and address significant unmet needs in infectious disease, oncology, agriculture, and other areas. By enabling testing anywhere, everywhere, Sherlock aims to improve health outcomes worldwide and foster global health equity.

Sherlock Biosciences promotes a culture of boldness, excellence, and growth, fostering an environment where employees feel respected, empowered, and accountable. They prioritize diversity, equity, and inclusion, believing that a diverse team fosters innovation. The company actively encourages employees to take ownership of their careers and achieve their personal goals while contributing to the shared mission of improving global health outcomes through revolutionary diagnostics.

Sherlock Biosciences embraces diversity, equity, and inclusion as core values, striving to build a community of well-rounded professionals from diverse backgrounds, ethnicities, nationalities, educational backgrounds, and genders. They believe that this "melting pot" of differences fosters innovation and ideas, extending their commitment beyond their workplace to underserved domestic and global communities through initiatives like their employee-run Internship & Co-op program and their 221b Foundation.